Sihuan Pharmaceutical's Self-Developed Innovative Oncology Drug Pirotinib Commenced Phase II Clinical Trial in China

Sihuan Pharmaceutical's Self-Developed Innovative Oncology Drug Pirotinib Commenced Phase II Clinical Trial in China

Led by Top Oncologist Professor Wu Yilong Expected to Commence Phase III Clinical Trial in 2H2019 Demonstrates Strong R&D Capability   Solidifies Oncology Drug Development Strategy HONG KONG, CHINA  – Media OutReach  – 13 August 2018 – Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) (“Sihuan Pharmaceutical ” or the “Group “), the largest cardio-cerebral vascular (“CCV “) drug manufacturer in […]

Has Amyloid-Based Research Turned The Corner?

Has Amyloid-Based Research Turned The Corner?

FILE – This Oct. 7, 2003 file photo shows a section of a human brain with Alzheimer’s disease on display at the Museum of Neuroanatomy at the University at Buffalo, in Buffalo, N.Y. On Wednesday, July 25, 2018, two drug makers said an experimental therapy slowed mental decline by 30 percent in patients who got […]

Grant links Yale to prestigious stroke clinical trial network

Grant links Yale to prestigious stroke clinical trial network

Yale has received a grant to support the SPIRIT (Southern New England Partnership in Stroke Research, Innovation, and Treatment) Coordinating Center in StrokeNet. Partnering with Brown University and Hartford Healthcare, the consortium has become one of 29 National Institutes of Health (NIH) StrokeNet clinical trial sites, advancing stroke treatment, stroke prevention, and recovery and rehabilitation […]

American College of Rheumatology receives grant to help increase access to clinical trials

American College of Rheumatology receives grant to help increase access to clinical trials

ATLANTA, July 31, 2018 — The American College of Rheumatology (ACR) today announced the receipt of two, two-year grants from the Office of Minority Health (OMH) to support the development of programs that aim to increase the recruitment and enrollment in lupus clinical trials of minority populations affected by lupus. “This is the sixth year […]

India poised to become 'one of the largest clinical trial hubs,' says CRO

India poised to become 'one of the largest clinical trial hubs,' says CRO

George Clinical, a contract research organization (CRO) operating in the Asia-Pacific region, including India, said it welcomes the ongoing efforts of the Central Drugs Standard Control Organization (CSDCO​) of India to improve timelines and submission approval rates.  Vanaja Krishnan, managing director of George Clinical, India, said “ambiguity and uncertainty”​ surrounding regulatory procedures and “growing ethical […]

Cancer Prevention Pharmaceuticals Completes North American Licensing Deal with Mallinckrodt

Cancer Prevention Pharmaceuticals Completes North American Licensing Deal with Mallinckrodt

License includes 50/50 profit share and additional payments of up to $185 million dependent on achieving clinical development and sales milestones, and subject to certain reductions Phase 3 clinical trial results for CPP-1X/sul in patients with familial adenomatous polyposis expected in 1H 2019 TUCSON, Ariz.–(BUSINESS WIRE)–Cancer Prevention Pharmaceuticals, Inc. (CPP), a private biotech company developing […]

Yoga, Depression, & Clinical Trial Critique 101

Yoga, Depression, & Clinical Trial Critique 101

  A study piqued my curiosity in a news feed recently. Yoga could reduce depression symptoms, researchers said – but only if you expected it to (Uebelacker 2018). Yoga for depression, it turns out, is pretty typical of lots of health issues and claims: an important topic, lots of hype. Here’s a classic example. Last year, Time magazine […]

1 2 3 125